Urinary 8-epi-PGF2α and its endogenous β-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress

This publication has 26 references indexed in Scilit:

• Quantification of 8-iso-prostaglandin-F2α and 2,3-dinor-8-iso-prostaglandin-F2α in human urine using liquid chromatography-tandem mass spectrometry
  Free Radical Biology and Medicine, 2003
• Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F2t-Isoprostane (8-iso-PGF2α) by a stable isotope dilution mass spectrometric assay
  Clinica Chimica Acta, 2001
• Measures of oxidative stress in heterozygous familial hypercholesterolaemia
  Atherosclerosis, 2001
• Enhanced In Vivo Lipid Peroxidation at Elevated Plasma Total Homocysteine Levels
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• F₄ ‐ Isoprostanes as Specific Marker of Docosahexaenoic Acid Peroxidation in Alzheimer's Disease
  Journal of Neurochemistry, 1999
• Metabolism of 8‐iso‐prostaglandin F_2α
  FEBS Letters, 1998
• The isoprostanes: Unique bioactive products of lipid peroxidation
  Progress in Lipid Research, 1997
• Identification of the Major Urinary Metabolite of the F2-isoprostane 8-Iso-prostaglandin F2α in Humans
  Journal of Biological Chemistry, 1996
• Plasma 8‐epi‐PGF_2α levels are elevated in individuals with non‐insulin dependent diabetes mellitus
  FEBS Letters, 1995
• Prostaglandins
  Annual Review of Biochemistry, 1975